TuHURA Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- TuHURA Biosciences's estimated annual revenue is currently $4.3M per year.
- TuHURA Biosciences's estimated revenue per employee is $155,000
- TuHURA Biosciences's total funding is $94M.
Employee Data
- TuHURA Biosciences has 28 Employees.
- TuHURA Biosciences grew their employee count by 4% last year.
TuHURA Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Quality Assurance (GxP) | Reveal Email/Phone |
2 | Director Translational Research | Reveal Email/Phone |
TuHURA Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $17.5M | 113 | 14% | N/A | N/A |
#2 | $1.9M | 12 | 0% | N/A | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $4.5M | 29 | 21% | N/A | N/A |
#5 | $4.8M | 31 | 11% | N/A | N/A |
#6 | $3.1M | 20 | N/A | N/A | N/A |
#7 | $0.8M | 5 | 0% | N/A | N/A |
#8 | $1.1M | 7 | 0% | N/A | N/A |
#9 | $2.6M | 17 | 6% | N/A | N/A |
#10 | $0.6M | 4 | -56% | N/A | N/A |
What Is TuHURA Biosciences?
TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company’s technologies are designed to overcome primary and acquired resistance to checkpoint inhibitors or cellular therapies in the treatment of cancer.
keywords:N/A
$94M
Total Funding
28
Number of Employees
$4.3M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Tampa
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.1M | 28 | 0% | N/A |
#2 | $6.5M | 28 | N/A | N/A |
#3 | $2.8M | 28 | N/A | N/A |
#4 | $3.4M | 28 | 17% | N/A |
#5 | $5.7M | 28 | -10% | N/A |